WallStreetZenWallStreetZen

NYSE: RCUS
Arcus Biosciences Inc Stock Ownership - Who owns Arcus Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arcus Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Juan C. JaenPresident2025-12-0482,997$24.71
$2.05MSell
Ii Robert C. GoeltzChief Financial Officer2025-11-265,000$25.00
$125.00kSell
Alexander AzoyChief Accounting Officer2025-11-261,900$13.33
$25.33kBuy
Alexander AzoyChief Accounting Officer2025-11-261,900$26.00
$49.40kSell
Juan C. JaenPresident2025-11-185,050$19.75
$99.74kSell
Juan C. JaenPresident2025-11-177,836$20.71
$162.31kSell
Juan C. JaenPresident2025-11-1737,114$20.23
$750.70kSell
Jennifer JarrettChief Operating Officer2025-11-0750,291$18.97
$954.07kSell
Jennifer JarrettChief Operating Officer2025-11-0750,291$1.23
$61.76kBuy
Juan C. JaenPresident2025-10-304,314$20.32
$87.65kSell

1 of 3

RCUS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RCUS insiders and whales buy or sell their stock.

RCUS Shareholders

What type of owners hold Arcus Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc29.10%31,424,760$676.58MInstitution
Gilead Sciences Inc29.10%31,424,760$676.58MInsider
Terry J. Rosen13.64%14,731,646$317.17MInsider
Blackrock Inc10.94%11,810,866$254.29MInstitution
Vanguard Group Inc6.14%6,629,453$142.73MInstitution
Point72 Asset Management LP4.01%4,332,479$93.28MInstitution
Woodline Partners LP3.49%3,769,684$81.16MInstitution
Suvretta Capital Management LLC3.42%3,688,858$79.42MInstitution
State Street Corp3.14%3,394,854$73.09MInstitution
Gv 2016 GP LLC2.89%3,125,312$67.29MInsider

1 of 3

RCUS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RCUS64.05%35.95%Net BuyingNet Selling
IBRX14.52%7.76%Net Selling
HRMY76.18%23.82%Net SellingNet Selling
MESO0.28%0.00%
ADPT62.17%37.83%Net SellingNet Selling
View Top Biotech Stocks

Arcus Biosciences Stock Ownership FAQ

Who owns Arcus Biosciences?

Arcus Biosciences (NYSE: RCUS) is owned by 93.18% institutional shareholders, 52.30% Arcus Biosciences insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Arcus Biosciences shareholder, owning 31.42M shares representing 29.10% of the company. Gilead Sciences Inc's Arcus Biosciences shares are currently valued at $676.58M.

If you're new to stock investing, here's how to buy Arcus Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.